McDonald's Tests High Protein Menu As GLP-1 Weight-Loss Drug Users Surge

McDonald’s Corporation (NYSE:MCD) is adapting its menu as a growing number of Americans on GLP-1 weight-loss drugs, such as Ozempic and Wegovy, alter portion sizes, snacking habits, and beverage choices. McDonald's Tests High-Protein Options For GLP-1 Users During a Wednesday earnings call, CEO Chris Kempczinski said McDonald's is testing menu items to appeal to customers taking GLP-1 medications. "As adoption grows, we know that consumers’ behavior changes," Kempczinski said. He noted these customers te ...